We used a log rank test to confirm that the WGCNA patient groups were highly related to cancer survival, and then checked that these patient groups could not be exclusively defined by clinical variables (stage, grade, Her2+, ER+, PR+, tumor size, lymph node involvement and metastasis). Here, ERBB2 is linked to cancer.